VM4 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Vanda Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 6.385 EUR 3.82% Market Closed

Market Cap: €371.6m

V	Vanda Pharmaceuticals Inc F:VM4	US
R	Rockwool A/S F:R90	DK
O	ON Semiconductor Corp F:XS4	US
C	Canadian Tire Corporation Ltd F:YAAA	CA
S	Sumitomo Realty & Development Co Ltd SWB:RL2	JP

Profitability Summary

Vanda Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

94%

Strong 3Y Average Gross Margin

93%

Gross Margin is Increasing

91% > 94%

Negative Operating Margin

-70%

Negative 3Y Average Operating Margin

-23%

Declining Operating Margin

6% > -70%

Negative Net Margin

-102%

Negative 3Y Average Net Margin

-17%

Declining Net Margin

6% > -102%

Negative Free Cash Flow Margin

-51%

Negative 3Y Average Free Cash Flow Margin

-10%

Declining Free Cash Flow Margin

23% > -51%

Negative ROE

-51%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-21%

Declining ROIC

7% > -104%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.